Dr. Jeffrey J. Atkinson, MD
Pulmonology (Pulmonary Disease Physician)
4921 Parkview Pl, Div Im Pulmonary And Ccm, 8th Fl
Saint Louis, MO 63110
- Medicare participating
At a glance
- Medical school
- Hahneman Medical College of the Pacific (1994)
- Years since graduation
- 32
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 1,651
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1994Medical school: Hahneman Medical College of the Pacific
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
MO license 2001026567
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Barnes Jewish Hospital Saint Louis, MO
Medical groups
- Washington University (3,029 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,651
- Services billed
- 5,320
- Patients’ average age
- 69
| Service | Times | Patients |
|---|---|---|
| Test to measure expiratory airflow and volume | 1,527 | 1,145 |
| Test for exercise-induced lung stress | 828 | 731 |
| Test to examine how well the lungs exchange gases | 643 | 627 |
| Test to determine lung volumes using sensors | 615 | 598 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 333 | 330 |
| Artery puncture collection of blood sample | 333 | 308 |
| Carboxyhemoglobin (protein) level | 322 | 298 |
| Blood gases measurement, with o2 saturation | 234 | 223 |
| Blood gases measurement | 90 | 89 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 64 | 42 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Trikafta (elexacaftor/tezacaftor/ivacaft) | 24 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $66.05 in total to this clinician.
| Vertex Pharmaceuticals Incorporated | $66.05 |
|---|
| Food and Beverage | $66.05 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $70,568 in research payments for these studies, mostly to the institutions running them.
- A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis
Vertex Pharmaceuticals Incorporated - A Phase III, randomised, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of BI 1291583 2.5 mg administered once daily for up to 76 weeks in patients with bronchiectasis (The AIR…
Boehringer Ingelheim International GmbH
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.